Table 6.
Top 10 areas for further research |
i. Effects of rhGH therapy in adults with PWS on quality of life |
ii. Long-term post-treatment effect of rhGH on mortality and morbidity using registries |
iii. The optimal timing and dosage of rhGH treatment initiation in early life |
iv. The effect of rhGH interruption at completion of growth |
v. Effects of rhGH on behavior and cognitive function across the age range |
vi. Impact of rhGH treatment on activities of daily living and well-being as defined by WHO |
vii. Influence of IGF-I titration on clinical effects |
viii. Effect of rhGH on glucose metabolism/diabetes risk, mainly long-term effect |
ix. Effects of rhGH therapy on sleep and sleep-disordered breathing in PWS adults |
x. RCTs investigating combination approaches to treatment |
Additional areas for future research |
xi. Effects of GH/IGF-I on nasopharyngeal tissue and mainly whether adenotonsillectomy changes the course or may avoid potential side effects of rhGH on sleep disorders and obstructive sleep apnea |
xii. Dose-response relationships investigating efficacy of physiological (rather than pharmacological) dosing |
xiii. Effects of rhGH treatment in children and adults on visceral adiposity and ectopic fat, eg, muscle, liver, and pancreas |
xiv. Effects of rhGH on timing of development or severity of hyperphagia |
xv. Effects of rhGH on bone maturation and premature pubarche |
xvi. Effects on structural brain development |
xvii. Scoliosis and slipped capital femoral epiphysis in children |
xviii. Is there hypersensitivity to rhGH in PWS? |
xix. Thyroid function before and after rhGH |
xx. Effects on cardiac function |
xxi. Effects of rhGH on lipid metabolism |
xxii. Effects of rhGH on water retention |
xxiii. Intracranial hypertension (difficult to assess in young children) |
All participants were asked to discuss areas for future investigation within breakout groups. All participants were then asked to order the areas, by priority, using a secret ballot.